Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Shih-chang Wang"'
Autor:
Hsiu-Wen Ho, Ching-Chieh Yang, Hsiu-Man Lin, Hsiao-Yun Chen, Chun-Chiao Huang, Shih-Chang Wang, Yu-Wei Lin
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract To evaluate the potential benefit of HyperArc (HA) fractionated stereotactic radiotherapy (FSRT) for the benign brain lesion. Sixteen patients with a single deep-seated, centrally located benign brain lesion treated by CyberKnife (CK, G4 con
Externí odkaz:
https://doaj.org/article/c8e904fe0a3d478895a452988d16985a
Autor:
Shou-Sheng Chu, Yu-Hsuan Kuo, Wen-Shan Liu, Shih-Chang Wang, Chung-Han Ho, Yi-Chen Chen, Ching-Chieh Yang, Hung-Chang Wu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) patients. This study aims to determine whether combining radiotherapy with sorafenib administration increases its efficacy. The study cohort included 4763 patien
Externí odkaz:
https://doaj.org/article/024fcee6fe3d4b1b8d21bbf35167f3b2
Autor:
Hsiu-Wen Ho, Steve P. Lee, Hisu-Man Lin, Hsiao-Yun Chen, Chun-Chiao Huang, Shih-Chang Wang, Ching-Chieh Yang, Yu-Wei Lin
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-11 (2020)
Abstract Background To evaluate dosimetric differences of salvage irradiations using two commercially available volumetric modulated arc therapy (VMAT) stereotactic body radiation therapy (SBRT) techniques: RapidArc (RA) and HyperArc (HA), for recurr
Externí odkaz:
https://doaj.org/article/1e1ab67b75a6400e986ee60e18ca7d83
Autor:
Shih-Chang Wang, Wei-Chen Ting, Yun-Ching Chang, Ching-Chieh Yang, Li-Ching Lin, Hsiu-Wen Ho, Shou-Sheng Chu, Yu-Wei Lin
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Whole pelvic radiotherapy (WPRT) with stereotactic body radiotherapy (SBRT) boost has been shown to be effective in patients with high-risk prostate cancer (PC). However, no study has directly compared the efficacy of WPRT with SBRT boost
Externí odkaz:
https://doaj.org/article/db0a46bf1a2a4708bcd0b64d3eb89c09
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: This study aims to assess the prognostic significance of radiographic numbers of positive pelvic lymph nodes (PLNs) in patients with cervical cancer treated with definitive concurrent chemoradiotherapy (CCRT) or intensity-modulated radiot
Externí odkaz:
https://doaj.org/article/87839445305a49d482cd63748fb1ede2
Autor:
Sinead P Blaber, Cameron J Hill, Rebecca A Webster, Jana M Say, Louise J Brown, Shih-Chang Wang, Graham Vesey, Benjamin Ross Herbert
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e52997 (2013)
Stem cells are increasingly the focus of translational research as well as having emerging roles in human cellular therapy. To support these uses there is a need for improved methods for in vivo cell localization and tracking. In this study, we exami
Externí odkaz:
https://doaj.org/article/007f4a430cb6446594926d88678bd338
Autor:
Yu-Wei Lin, Hsiao-Yun Chen, Hsiu-Wen Ho, Shih-Chang Wang, Hsiu-Man Lin, Ching-Chieh Yang, Chun-Chiao Huang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports
Scientific Reports
To evaluate the potential benefit of HyperArc (HA) fractionated stereotactic radiotherapy (FSRT) for the benign brain lesion. Sixteen patients with a single deep-seated, centrally located benign brain lesion treated by CyberKnife (CK, G4 cone-based m
Autor:
Yu-Wei Lin, Hsiu-Wen Ho, Hsiao-Yun Chen, Shih-Chang Wang, Hsiu-Man Lin, Chun-Chiao Huang, Ching-Chieh Yang
Publikováno v:
Medical Dosimetry. 46:164-170
The purpose of this study was to evaluate the feasibility and efficacy of HyperArc (HA) for recurrent nasopharyngeal cancer (NPC) by comparing it with the CyberKnife system (CK). Fifteen patients with recurrent nasopharyngeal cancer who were treated
Autor:
Ching-Chieh Yang, Sung-Wei Lee, Shou-Sheng Chu, Cheng-Yi Lin, Shih-Chang Wang, Tzu-Ju Chen, Chia-Lin Chou
Publikováno v:
OncoTargets and Therapy. 13:3141-3150
Background In a data mining search for potential therapeutic targets to improve the outcome of rectal cancer, we identified PCSK1 as the cell-cell signaling gene most significantly associated with poor response to concurrent chemoradiotherapy (CCRT).
Autor:
Yi-Chen Chen, Chung-Han Ho, Ching-Chieh Yang, Shou-Sheng Chu, Hung-Chang Wu, Yu-Hsuan Kuo, Shih-Chang Wang, Wen-Shan Liu
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) patients. This study aims to determine whether combining radiotherapy with sorafenib administration increases its efficacy. The study cohort included 4763 patients with d